ATX inhibitors

Oncology

Tackling the fibroblast cells that form scar tissue around tumours takes down a barrier that prevents or inhibits the effect of many therapies.

Patients

Rebecca Guntern, Sandoz' CCO, discusses the ‘golden decade’ for generics and biosimilars as so many blockbuster drugs come off patent.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.